Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Novavax Inc (NVAX)

NASDAQ
Currency in USD
Disclaimer
4.090
+0.140(+3.54%)
Closed
After Hours
4.010-0.080(-1.956%)

NVAX Comments

Let me help you all with some facts vs opinions, hunches & wishes. 1. Has NVAX been the benificiary of a Short Sq yes. 2. Their 89% efficacy vs JNJ is greyish data (JNJ incuded the SAfrica data on their results) NVAX SAfrica study was acording to them too small of a smample but came in at 60% efficacy less than JNJ not even to mention PFE /MNRA. 3. Most importantly everysingle vaccine stock has tummbed after the FDA issues out emergency authorizatio. Again everysingle one; PFE, BNTX, MDNA. AZN also fits that category. Mind you these co have an approved vaccine if rejected watchout. Eitherway it will go up until it’s approved. So the best thing for the stock is to keep eating time as regardelss of a solid or negative result it will tumbble hard. Good luck
Dude, this stock has gone from 20 to 280. we've all taken our profits. chill out .
and you're correct about making money on the way down but I'm not that sophisticated
Easy compare it to both Moderna & Biontech and while you are at it see how they both dis after their vaccines were approved. The market hardly ever gives you such a clear picture of what is going on and what will happen you just need to be open enough to see it
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.